Patient Safety and Radiopharmaceuticals Administration: Minimizing Radiation Exposure and Risks
Worldwide Clinical Trials
JULY 8, 2024
With radiopharmaceuticals emerging as a diagnostic and therapeutic (theranostics) procedure, many are in the clinical development pipeline and are expected to play a crucial role in the future of healthcare. The goal is to deliver a precise radiation dose to the diseased tissues while minimizing damage to surrounding healthy tissue.
Let's personalize your content